Endometrial Biopsy and Sampling

Endometrial biopsy and sampling are methods for obtaining endometrial tissue for histologic examination, most often to investigate abnormal uterine bleeding and to detect endometrial hyperplasia or carcinoma. Office-based aspiration devices have largely replaced dilatation and curettage as the first-line sampling technique because they provide comparable diagnostic information with less invasiveness.

Definition

Endometrial sampling is the retrieval of endometrial tissue, by aspiration biopsy (e.g., a thin flexible suction device) or by dilatation and curettage, for histopathologic evaluation of the endometrium.

Scope

This entry covers the rationale for endometrial sampling, the principal devices and their diagnostic accuracy, the histologic targets (hyperplasia and carcinoma), and how sampling relates to imaging-based assessment of the endometrium. It is a methodological reference and does not provide indications or thresholds for individual care.

Core questions

• How accurately do office sampling devices detect endometrial carcinoma and hyperplasia?
• How does aspiration biopsy compare with dilatation and curettage?
• How does tissue sampling complement endometrial imaging?
• What are the limits of a sampling result, including non-diagnostic or insufficient specimens?

Key concepts

• Aspiration (suction) biopsy
• Dilatation and curettage
• Histologic diagnosis of hyperplasia and carcinoma
• Sampling sensitivity and specificity
• Insufficient or non-diagnostic specimens
• Focal versus diffuse pathology
• Relation to endometrial thickness on ultrasound

Mechanisms

Endometrial sampling retrieves cells and tissue fragments from the endometrial lining for microscopic examination, allowing histologic classification of normal, hyperplastic, or malignant endometrium. Office aspiration devices generate negative pressure to draw a tissue sample through a narrow cannula, avoiding cervical dilatation and anaesthesia, whereas dilatation and curettage scrapes the cavity under more invasive conditions. Because sampling collects tissue from part of the cavity, its sensitivity is highest for diffuse disease and lower for focal lesions, which is why it is often paired with imaging that localizes abnormalities.

Clinical relevance

Endometrial sampling is a key step in evaluating abnormal uterine bleeding and in detecting endometrial precancer and cancer. The entry explains how the tissue diagnosis is obtained and how reliable it is; it describes the generation of diagnostic evidence and is not a basis for individual diagnostic or treatment decisions.

Epidemiology

Abnormal uterine bleeding, particularly postmenopausal bleeding, is the most common trigger for endometrial sampling, and endometrial carcinoma is among the most frequent gynecologic cancers. Meta-analytic evidence shows that aspiration sampling has high accuracy for detecting carcinoma when an adequate specimen is obtained, supporting its role as a first-line test.

History

Dilatation and curettage was historically the standard means of obtaining endometrial tissue. From the late twentieth century, thin office aspiration devices were introduced and validated, and a meta-analysis by Dijkhuizen and colleagues in 2000 established their high accuracy for detecting endometrial carcinoma, consolidating the shift toward less invasive office sampling.

Debates

Adequacy of blind sampling for focal lesions

Blind aspiration samples only part of the cavity and can miss focal lesions; this limitation underlies debate over when imaging-guided or hysteroscopically directed sampling should be preferred over office biopsy, and how to act on insufficient specimens.

Key figures

• Frank Dijkhuizen
• Ben Willem Mol

Seminal works

• dijkhuizen-2000

Frequently asked questions

Why has office aspiration biopsy largely replaced dilatation and curettage?

Aspiration devices provide comparable diagnostic accuracy for endometrial carcinoma while being performed in the office without cervical dilatation or anaesthesia, making them a less invasive first-line sampling method when an adequate specimen is obtained.

What does a negative or insufficient endometrial biopsy mean?

Because sampling examines only part of the cavity, a negative result does not fully exclude focal pathology, and an insufficient or non-diagnostic specimen may require further evaluation such as imaging or hysteroscopically directed sampling; interpretation is an individualized clinical judgement beyond the scope of this reference entry.